ARA-290
Symbol Ar · MW 1257 Da
EPO-derived peptide studied for nerve pain, inflammation and tissue protection.
- Discovered
- 2011
- Half-life
- 2 minutes
- Approval
- Investigational
Reported effects
- Neuropathic pain relief
- Tissue protection
- Anti-inflammatory
Overview
ARA-290, also known as Cibinetide, is a tissue-protective peptide derived from erythropoietin-related research. It is studied for its potential role in reducing inflammation, supporting nerve health, and promoting cellular repair. Unlike erythropoietin, ARA-290 is designed to activate tissue-protective pathways without increasing red blood cell production. It is commonly associated with recovery, neuropathy research, inflammation control, and tissue repair support. As a recovery peptide, ARA-290 is most often discussed for its potential benefits in nerve-related discomfort, immune regulation, and protection against cellular stress.
How it's taken
- Typical Administration
- Injectable
- Typical Dosage
- No established approved dosage; clinical research commonly uses 2–8 mg
- Typical Frequency
- Once daily or several times weekly depending on research protocol
Research sources
Source links included from peer-reviewed literature and trusted medical journal records for this peptide.
Interested in ARA-290?
Enter your email and we'll send you a curated list of vendors we trust for sourcing this peptide.
No spam · Unsubscribe anytime
For educational purposes only. Many peptides shown are research compounds and not approved for human use in all jurisdictions.